Literature DB >> 3067252

Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

B B Sherwin1.   

Abstract

The effect of estrogen and/or androgen replacement therapy on several aspects of cognitive functioning in surgically menopausal women was tested in a prospective, crossover design. Women who received either a combined estrogen-androgen preparation, estrogen alone, or androgen alone had scores on two tests of short-term memory, a test of long-term memory and a test of logical reasoning that were not different during the postoperative treatment phase compared to their preoperative performance. However, oophorectomized women who received placebo had lower scores on all four measures of cognitive functioning postoperatively, coincident with their significantly lower concentrations of plasma estradiol and testosterone. Patients who had a hysterectomy but whose ovaries were retained showed stability both in cognitive performance and in circulating sex steroid concentrations. These findings suggest that the drastic change in endocrine milieu following surgical menopause may have a direct, albeit modest, effect on aspects of cognitive functioning. Possible mechanisms of action of the sex hormones on cognitive functioning in women are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067252     DOI: 10.1016/0306-4530(88)90060-1

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  141 in total

Review 1.  HRT and its effect on normal ageing of the brain and dementia.

Authors:  J Compton; T van Amelsvoort; D Murphy
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Posttraining androgens' enhancement of cognitive performance is temporally distinct from androgens' increases in affective behavior.

Authors:  C A Frye; E H Lacey
Journal:  Cogn Affect Behav Neurosci       Date:  2001-06       Impact factor: 3.282

Review 3.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

Review 4.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 5.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 6.  Estrogen and cognitive functioning in women: lessons we have learned.

Authors:  Barbara B Sherwin
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

Review 7.  Gonadal hormones and cognitive aging: a midlife perspective.

Authors:  Victor W Henderson
Journal:  Womens Health (Lond)       Date:  2011-01

8.  Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life.

Authors:  Pauline M Maki; Lorraine Dennerstein; Margaret Clark; Janet Guthrie; Pamela LaMontagne; Deanne Fornelli; Deborah Little; Victor W Henderson; Susan M Resnick
Journal:  Brain Res       Date:  2010-11-13       Impact factor: 3.252

9.  A new semantic list learning task to probe functioning of the Papez circuit.

Authors:  Michael-Paul Schallmo; Michelle T Kassel; Sara L Weisenbach; Sara J Walker; Leslie M Guidotti-Breting; Julia A Rao; Kathleen E Hazlett; Ciaran M Considine; Gurpriya Sethi; Naalti Vats; Marta Pecina; Robert C Welsh; Monica N Starkman; Bruno Giordani; Scott A Langenecker
Journal:  J Clin Exp Neuropsychol       Date:  2015       Impact factor: 2.475

Review 10.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.